Celldex Therapeutics appoints board member
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Insight Weekly: Renewables lead capacity additions; bank mergers of equals up; nickel IPOs surge
Insight Weekly: Utilities face headwinds; S&P 500 dividend hikes likely; dollar poised for rally
Celldex Therapeutics Inc. appointed Gerald McMahon to its board of directors.
Board member Richard van den Broek resigned, "due to increasing responsibilities in other endeavors," the company said.
McMahon was previously the president and CEO of Kolltan Pharmaceuticals.
Hampton, N.J.-based Celldex develops therapeutics for the immune system.
